News & Announcements
-
IQ-AI announces 2019 results
Year highlighted by increased market footprint, FDA clearance for StoneChecker, new product development initiatives. Read full report.
-
IQ-AI announces 2018 results
Year highlighted by acquisition of Imaging Biometrics, laying foundation for access to broader markets. Read full report.
-
IB Software Key to Proposed Brain Tumor Consensus Standard
IB Neuro and IB Delta Suite are critical components in analyzing low-dose MRI perfusion data, featured in a study published in the American Journal of Neuroradiology.
-
IQ-AI’s Imaging Biometrics appoints South Korean distributor
IQ-AI’s Imaging Biometrics Appoints South Korean Distributor as it Receives Regulatory Certification IQ-AI Limited (LON:IQAI) — The investment firm said that IB’s distributor would sell its full range of imaging products relating to brain tumour detection in the country.
-
IQ-AI Receives first commercial order for StoneChecker